PhD, Chemical Engineer
Senior Lecturer
- About
-
- Email Address
- l.trembleau@abdn.ac.uk
- Telephone Number
- +44 (0)1224 272922
- Office Address
Telephone: +44 (0)1224 272922 Address: School of Natural and Computing Sciences University of Aberdeen Meston Building, Room G95 Aberdeen AB24 3UE
- School/Department
- School of Natural and Computing Sciences
Biography
Laurent Trembleau received his undergraduate education at the "Institut Universitaire de Technologie" of Orléans (France) and obtained a "Diplôme d'Ingénieur" in Fine Chemistry and Engineering, and a "Diplôme d'Etudes Approfondies" (DEA) in Chemistry at the "Institut National des Sciences Appliquées" of Rouen, France (1993). In 1994, he moved to Louvain-la-Neuve (Belgium) to undertake a PhD in the group of Professor Léon Ghosez. His work, financed by Rhône-Poulenc Rorer, involved the development of new Diels-Alder reactions and methods towards the synthesis of ottelione A, a natural product inhibitor of tubulin polymerisation. In 2001, he moved to the Scripps Research Institute (USA) for a 2-year post-doctoral position in the group of Professor Julius Rebek where he designed a water-soluble receptor of acetylcholine, described the helical conformation of alkanes in synthetic receptors, and was involved in the synthesis of oxazole-based macrocycles. In 2004, he did a short post-doctoral position in the group of Dr Simon Webb, where he worked on the synthesis of novel lipids designed to mimic cell adhesion molecules. At the end of 2004, he accepted a Lectureship in Medicinal Chemistry at the University of Aberdeen, where he is currently studying the total synthesis and SAR of bioactive molecules, the development of organic catalysts and novel methods for application in Organic Synthesis and Medicinal Chemistry.
- Research
-
Current Research
1) Methodology
Peptide Synthesis
We are interested in the development of efficient solution and solid-phase syntheses of peptides. We have recently optimized a repetitive procedure that contains features from both solid-phase and solution-phase methods, making it an effective method for the synthesis of short peptides. We are currently modifying resins to improve the synthesis of "difficult peptide sequences".
Supramolecular Chemistry
1) We are investigating the properties of novel organocatalysts that mimic the residues of enzymes involved in catalysis.
2) We are developing new foldamers with the aim to bind anions (especially fluoride) in aqueous media.
2) Medicinal Chemistry
Inhibitors of Protein-Protein Interactions (PPI): This project involves the design and synthesis of inhibitors of protein-protein interactions. We are developing macrocyclic molecules possessing large surface areas in the aim to inhibit specific protein-protein interactions (in collaboration with Prof M. Jaspars, Dr W. Houssen, and Prof J. Naismith).
Funding and Grants
- European Commission "New Chemical Biology for Tayloring Novel Therapeutics - PDRA (2014-2019) (with Prof Marcel Jaspars and Prof Jim Naismith)
- Scottish Enterprise "Validation of the Commercial Potential of Diversity-Oriented Biosynthesis to Create Novel Macrocycle Drugs" - (2015-2016) with Prof Marcel Jaspars, Prof Jim Naismith and Dr Wael Houssen.
- Teaching
-
Teaching Responsibilities
Dr Trembleau teaches in the following courses
- CM1022 Elements of Chemistry 1 (2 lectures)
- CM2512 Organic and Biological Chemistry (8 lectures)
- CM3521 Organic and Biological Chemistry (12 lectures)
- CM4516 Honours/Advanced Chemistry (12 lectures)
- CM5003 MChem Chemistry Applications (10 lectures)
- Publications
-
Page 4 of 6 Results 31 to 40 of 59
Discovery of a Single Monooxygenase that Catalyzes Carbamate Formation and Ring Contraction in the Biosynthesis of the Legonmycins
Angewandte Chemie International Edition, vol. 54, no. 43, pp. 12697-12701Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/anie.201502902
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists
Acta Crystallographica Section E: Structure Reports Online, vol. 71, no. 6, pp. 654-659Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1107/S2056989015008476
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4627/1/lh5763.pdf
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
Behavioural Pharmacology, vol. 25, no. 2, pp. 182-185Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/FBP.0000000000000027
Isolation and Synthesis of Pulmonarins A and B, Acetylcholinesterase Inhibitors from the Colonial Ascidian Synoicum pulmonaria
Journal of Natural Products, vol. 77, no. 2, pp. 364-369Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1021/np401002s
Receptor conformational change induces fluoride binding despite competitive water binding
Chemical Communications, vol. 49, no. 52, pp. 5850-5852Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1039/c3cc43019g
The mechanism of patellamide macrocyclization revealed by the characterization of the PatG macrocyclase domain
Nature Structural & Molecular Biology, vol. 19, no. 8, pp. 767-772Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/nsmb.2340
Development of 18F-fluorinatable dendrons and their application to cancer cell targeting
New Journal of Chemistry, vol. 35, no. 11, pp. 2496-2502Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1039/C1NJ20417C
18F-PEG-biotin: Precursor (boroaryl-PEG-biotin) synthesis, 18F-labelling and an in-vitro assessment of its binding to NeutravidinTM -trastuzumab pre-treated cells
Applied Radiation and Isotopes, vol. 69, no. 10, pp. 1395-1400Contributions to Journals: ArticlesChanges in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab
Nuclear Medicine and Biology, vol. 38, no. 3, pp. 339-346Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.nucmedbio.2010.09.005
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/2099/1/acm_paper.pdf
N-(ARYLALKYL)-1H-INDOLE-2-SULFONIC ACID AMIDE COMPOUNDS AND THEIR THERAPEUTIC USE AS CANNABINOID ALLOSTERIC MODULATORS
Patents: Patents